Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled Trial

97

Citations

25

References

2006

Year

Guillaume Chevrel, Anne‐Marie Schott, Élisabeth Fontanges, J. Charrin, Geneviève Lina‐Granade, F. Duboeuf, Patrick Garnero, M. Arlot, Claude Raynal, Pierre J. Meunier

Journal of Bone and Mineral Research

Abstract

Oral alendronate increases BMD and increase nonsevere gastrointestinal adverse effects but does not modify the hearing loss in adult patients with osteogenesis imperfecta. More studies are needed to evaluate an effect on the fracture rate.

References

	Year	Citations

Page 1